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ABSTRACT  
 
Background: The success of rotator cuff repair is primarily dependent upon tendon-
bone healing. Failure is common because weak scar tissue replaces the native 
enthesis, rendering it prone to re-rupture. Demineralised bone matrix (DBM) consists 
of a network of collagen fibers that provide a sustained release of growth factors such 
as bone morphogenic proteins (BMPs). Previous studies have demonstrated that it can 
regenerate a fibrocartilaginous enthesis. 
 
Hypothesis: The use of DBM and MSCs at the healing enthesis will result in a higher 
bone mineral density at the tendon insertion and enhances the regeneration of a 
morphologically superior enthesis when compared to acellular human dermal matrix.  
 
Study design: Controlled Laboratory Study.  
 
Methods: Eighteen female Wistar rats underwent unilateral detachment of the 
supraspinatus tendon. Three weeks later, tendon repair was carried out in animals 
randomized into three groups: Group 1 received augmentation of the repair with 
cortical allogenic DBM (n = 6); Group 2 received augmentation with non-meshed, 
ultra-thick acellular human dermal matrix (n = 6); and Group 3 underwent tendon-
bone repair without a scaffold (n = 6). All animals received 1 × 106 MSCs delivered 
in fibrin glue to the repair site. Specimens were retrieved at six weeks postoperatively 
for histological analysis and evaluation of bone mineral density.  
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Results: All groups demonstrated closure of the tendon-bone gap with a 
fibrocartilaginous enthesis. Although there were no significant differences in the 
enthesis maturation and Modified Movin scores, repairs augmented with dermal 
matrix + MSCs exhibited a disorganised enthesis, abnormal collagen fiber 
arrangement, and greater cellularity compared to other MSC groups. Only repairs 
augmented with DBM + MSCs reached a bone mineral density not significantly lower 
than non-operated controls.  
 
Conclusion: DBM enhanced with MSCs can augment rotator cuff healing at six 
weeks and restore bone mineral density at the enthesis to its pre-injury levels.  
 
Clinical Relevance: Biological augmentation of rotator cuff repair with DBM and 
MSCs may reduce the incidence of retears, although further studies are required to 
determine its effectiveness.  
 
Key Terms: demineralised bone matrix; mesenchymal stem cells; rotator cuff; 
tendon-bone healing.   
 
What is known about the subject: Tears of the rotator cuff are one of the most 
common tendon disorders. Treatment often includes surgical repair but the rate of 
failure to gain or maintain healing has been reported to be as high as 94%. This has 
been substantially attributed to the reduced capacity of tendon to heal once damaged, 
particularly to bone at the enthesis. Several strategies to improve tendon-bone healing, 
tendon-tendon healing, and tendon regeneration have been developed. Scaffolds have 
received considerable attention for replacement, reconstruction, or reinforcement of 
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tendon defects but may not possess situation-specific or durable mechanical and 
biological characteristics.  
 
Demineralised bone matrix is routinely used as a bone graft substitute material and is 
composed of a type 1 collagen matrix that contains multiple growth factors believed 
to enhance bony regeneration through endochondral ossification. Few studies have 
examined the effects of demineralised bone matrix on tendon healing, with those that 
do demonstrating that it can regenerate a histologically normal enthesis in both acute 
tear and tendon retraction models.  
 
What this study adds to existing knowledge: This is the first study to investigate the 
effect of mesenchymal stem cells on the action of demineralised bone matrix in a 
small animal model of a chronic rotator cuff tear.     
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INTRODUCTION  
 
Approximately 75,000 rotator cuff repairs are performed each year in the United 
States. 50 Up to 46% of tendons fail to heal back to bone and result in a worse 
functional outcome than those tendons that do go onto heal. 6 The native enthesis is a 
graduated structure that allows stresses to be evenly distributed between tendon and 
bone. 43 Following surgery, scar tissue is deposited at the healing interface and has 
been identified as a potential cause of the high failure rate because it possesses weak 
mechanical properties and does not contain mineralised fibrocartilage. 11, 38 11, 14, 25, 38 
In order to improve rotator cuff healing, biological strategies must enhance tissue 
regeneration in order to provide mechanically resilient tissues able to resist tearing 
during the crucial postoperative rehabilitation period. 29      
 
Mesenchymal stem cells (MSCs) are multipotent cells that are capable of 
differentiating into several cell types, including chondrocytes, adipocytes, and 
osteoblasts. 7 In vivo examination of the behaviour of MSCs in enthesis regeneration 
have reported the absence of a fibrocartilaginous interface, citing the lack of signaling 
as a reason for the transplanted cells not differentiating and leading to a poor 
outcome. 17 To enhance their effect, studies have engineered stem cells in vitro to 
express specific proteins. 18, 19 In doing so, the addition of these cells has increased 
fibrocartilage production and improved the strength of the repair. 18   
 
Demineralised bone matrix (DBM) consists of a network of collagen fibers that 
provide a sustained release of growth factors such as bone morphogenic proteins 
(BMPs). 33, 40 Wurgler-Hari et al 51 demonstrated that a slow release of growth factors 
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is required for tendon-bone healing, and there is evidence to indicate that BMPs are 
important proponents of a naturally graduated, mechanically favorable enthesis. 3, 28, 32 
Differentiation of MSCs can be directed by the introduction of BMPs; a property that 
may be utilised to increase production of mineralised fibrocartilage at the healing 
enthesis. 12, 16, 26, 39 DBM has been shown to regenerate a strong enthesis with 
mineralised fibrocartilage in both acute and chronic tear models of tendon-bone 
healing. 40, 41 Similar results have additionally been demonstrated in a large animal 
model of severe tendon retraction. 42 Since the ultimate strength of the tendon-bone 
interface is dependent upon bony ingrowth and the development of fibrocartilage, we 
speculate that the addition of MSCs into a DBM-based repair construct will produce 
an enthesis resembling the native insertion site with a natural gradation between 
tendon, demineralised fibrocartilage, mineralised fibrocartilage, and bone.      
 
The purpose of this study was to determine if DBM enhanced with MSCs could 
improve tendon-bone healing when applied to a degenerative rotator cuff tear model. 
We compared DBM with a commercially available human dermal matrix graft, which 
has been used clinically for enthesis repair (GraftJacket [Wright Medical Technology, 
Inc., Arlington, TN (Tennessee)]). The hypothesis was that in a rat model of chronic 
rotator cuff tear, the addition of DBM and MSCs to the healing enthesis would result 
in a higher bone mineral density at the tendon insertion and this combination would 
lead to regeneration of a morphologically superior enthesis characterized by greater 
fibrocartilage formation and improved collagen fiber organization in a rat model of a 
chronic rotator cuff tear when compared to acellular human dermal matrix.  
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Furthermore, to determine whether MSCs could enhance the structure of the healing 
enthesis compared to repairs without stem cells, the results of this experiment were 
compared to a previously published study that utilised the same animal model and 
scaffolds. 41 It was hypothesised that the addition of MSCs would yield a 
morphologically superior interface and increased bone mineral density at the tendon 
insertion. 
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MATERIALS AND METHODS 
 
Study Design 
 
All animal work was conducted in accordance with a Project License protocol 
accepted under the UK Home Office Animals (Scientific Procedures) Act 1986. 
Eighteen female Wistar rats underwent unilateral detachment of the supraspinatus 
tendon, and an additional one animal from the same genus was used to obtain bone 
marrow-derived MSCs. Previously published data was used to calculate the number 
of animals (n = 6) required to generate a power of 0.8 with significance at the 0.05 
level. 40 It has demonstrated that detachment of the supraspinatus tendon in rats 
results in morphological changes similar to those that occur in the clinical setting. 5 
After three weeks, tendon repair was carried out in animals randomised into three 
groups: Group 1 received augmentation of the repair with cortical allogenic DBM (n 
= 6); Group 2 received augmentation with non-meshed, ultra-thick acellular human 
dermal matrix (n = 6) (GraftJacket, Wright Medical Technology, Inc., Arlington, TN; 
average 1.4mm thickness); and Group 3 underwent tendon-bone repair without a 
scaffold (n = 6). All animals received 1 × 106 MSCs in a fibrin sealant (Tisseel® kit, 
Baxter, Vienna, Austria) and one animal from each study group received MSCs 
labeled with Quantum Dot nanoparticles (Qtracker 655, Invitrogen, Massachusetts, 
United States) (QDs) for cell tracking. In order to minimise the number of animals 
used, as per UK Home Office regulations, fibrin glue devoid of MSCs was not used as 
an experimental group as it has previously been shown not to enhance healing of the 
enthesis. 17, 37, 52  
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One surgeon carried out all procedures using a standard technique. Animals were 
allowed to mobilise freely after surgery. Specimens were retrieved at six weeks 
postoperatively for histological analysis and peripheral quantitative computer 
tomography (pQCT) to evaluate bone mineral density (BMD) at the reattachment 
footprint of the tendon, reversal of degenerative changes within the tendon, and 
histological remodeling of the implanted augmentation material.   
 
Acellular human dermal matrix preparation 
 
GraftJacket (Wright Medical Technology, Inc., Arlington, TN) is obtained from 
donated human cadaveric dermal tissue processed to remove its cellular components 
whilst retaining its extra-cellular matrix. Its acellularity has the advantage of not 
causing a host inflammatory reaction and it has been safely used in rats to enhance 
healing of a large acute rotator cuff tear. 21 Samples of dermal matrix were rehydrated 
at the time of surgery in normal saline for 30 minutes prior to use.  
 
DBM Manufacture 
  
DBM derived from cortical bone was manufactured according to Urist’s protocol, 
with modifications. 47 The tibiae of skeletally mature female Wistar rats were 
harvested immediately after euthanasia; all soft tissues and periosteum were stripped 
from the bone surface. Bones measuring approximately 30 mm length by 3 mm width 
were demineralized in 0.6 N HCL at room temperature (Figure 1). Demineralization 
was confirmed by taking radiographs (300 seconds, 30 kV, Faxitron Corporation, 
Illinois, USA). This was followed by washing in phosphate-buffered saline (PBS) 
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until the pH was 7.4 +/- 0.1. Samples were stored at -20 ̊ C for two hours and 
transferred to a lyophiliser (Edwards Girovac Ltd, Crawley, West Sussex, UK) for 
three days (Figure 2). Specimens were then sealed in individual plastic bags, sterilised 
by gamma irradiation at a dose of 25 kilograys (Isotron Limited, Reading, UK), and 
stored at -20 ̊ C. Samples were rehydrated at the time of surgery in sterile saline 
solution for 30 minutes prior to use.  
 
 
 
Figure 1. Rat tibiae following demineralisation.  
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Figure 2. Demineralised rat tibiae in lyophiliser.  
 
Bone Marrow-Derived Mesenchymal Stem Cell Harvest and Culture  
 
One six-month-old female Wistar rat was euthanised by carbon dioxide inhalation and 
bilateral femurs were harvested under sterile conditions. MSCs were harvested by 
lavaging the intramedullary canals with Dulbecco's modified Eagle's medium 
(DMEM) (Invitrogen, Paisley, UK) containing 10% fetal calf serum (FCS) (HyClone, 
Logan, Utah, USA) and 1% penicillin/streptomycin solution (ThermoFisher 
Scientific, United States), to obtain a bone marrow aspirate, which was plated onto T-
75 culture flasks. Cells were cultured at 37°C in a 5% carbon dioxide incubator. After 
five days, the contents of the flask were removed and washed with media, leaving the 
MSCs that adhered to the bottom of the flask. Afterwards, media was changed twice a 
week for 14 days. Once confluent, the MSCs were detached with trypsin and serially 
subcultured. Third passage cells were used for implantation. Previous studies have 
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shown that this protocol is a reliable method of obtaining MSCs, and that their 
pluripotency is maintained up to the third passage. 1, 17, 18, 34, 46 No immunogenic 
reaction was anticipated with stem cell implantation because the rats from which cells 
were harvested were the same strain as those receiving them.  
  
Surgical Technique 
 
Two surgeries were performed on each animal: full-thickness supraspinatus tendon 
detachment and complete tendon reattachment. Anaesthesia was induced and 
maintained using 2% isoflurane mixed with pure oxygen via a facemask for both 
procedures. The right shoulder was operated on in all cases. A 1.5 cm skin incision 
was made directly over the anterolateral border of the acromion. The deltoid was 
detached from the acromion and split caudally for 0.5 cm, in order to identify the 
tendon of supraspinatus. The supraspinatus tendon was completely detached from its 
bony insertion on the humeral head, marked with a 5’0 Prolene suture (Ethicon, 
Johnson & Johnson Medical Ltd., Berkshire, UK) at the musculotendinous junction 
(MTJ), and allowed to retract medially. Deltoid muscle, superficial fascia, and skin 
were closed with 5’0 Vicryl suture (Ethicon, Johnson & Johnson Medical Ltd., 
Berkshire, UK). Animals were allowed unrestricted cage activity and received 
analgesia (subcutaneous buprenorphine) every 12 hours for three days. The second 
surgery to reattach the tendon was undertaken three weeks after the first procedure. 
Prior to making the skin incision, the DBM or dermal matrix was rehydrated for 30 
minutes in sterile normal saline at the operating table. 4   
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A 2 cm skin incision was made in line with the supraspinatus muscle belly, ending 
anterior to the lateral end of the clavicle. This approach was perpendicular to the 
incision used for tendon detachment in order to make use of a virgin anatomical plane 
devoid of scar tissue. The muscle belly of supraspinatus was identified and followed 
distally to reveal the tendon stump with the suture marker in the MTJ. Scar tissue 
between the tendon stump and its insertion was excised and the tendon was grasped 
with a double-armed 5’0 prolene using a modified Mason-Allen technique. 44 Despite 
traction on the tendon stump, it could not be directly brought back to the humeral 
head in any of the cases. The bare tendon-bone insertion footprint was decorticated 
using a #11 surgical blade until bleeding was seen. A custom-made dental drill was 
used to drill a 1 mm hole from the neck of the humerus to the bony insertion of the 
detached supraspinatus.  
 
MSCs were incorporated into the repair construct using a fibrin sealant [Tisseel® 
(Baxter, Vienna, Austria)] that contained two parts: a vapor-heated Tisseel® powder 
dissolved in aprotinin solution and a vapor-heated thrombin powder, dissolved in 
calcium chloride solution. One milliliter of the Tisseel® solution contained 100–130 
mg of total protein, of which 75–115 mg was fibrinogen. One milliliter of thrombin 
solution contained 45–55 mg of total protein, of which 500 International Units (IU) 2 
was thrombin. 24 Preoperatively, MSCs were implanted into the thrombin component 
in vitro at a concentration of 1 × 106 cells/100 μl and mixed with the Tisseel® 
solution. The fibrin glue was injected into a custom-made square-shaped stainless 
steel mold measuring 1 cm by 1cm containing DMEM, which provided nutrition to 
the cells up to the point at which they were implanted (Figure 3).  
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Figure 3. Metallic molds containing fibrin glue and MSCs in vitro. 
 
Each limb of the suture was passed through the scaffold to secure it in position. One 
suture limb was passed through the hole in the prepared tendon stump and the other 
suture limb was passed through the hole on the neck of the humerus. The 
supraspinatus tendon-scaffold complex was attached to the insertion site, with the 
graft in contact with both the tendon stump proximally and decorticated bone surface 
distally. In the control group the sutures were inserted directly into the drill holes, 
leaving a 5 mm gap between the tendon and bone in all cases.  
 
Prior to securing the graft material (cortical DBM or dermal matrix) during tendon 
reattachment surgery, the sheet of fibrin glue containing MSCs was placed on the 
decorticated humeral head whilst lying in contact with the proximal tendon stump 
(Figure 4). All grafts used to augment healing measured approximately 1.5 cm in 
length and 3-5 mm in width.  
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Figure 4. Supraspinatus tendon-bone interface with cortical DBM + MSCs (A) and 
dermal matrix + MSCs (B).  
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In the group where MSCs were used in isolation, the fibrin glue bridged the gap 
between the retracted supraspinatus musculotendinous unit and its bony insertion. The 
repair construct resembled a laminated structure: superficial layer – cortical 
DBM/dermal matrix, central layer – fibrin glue with MSCs, and deep layer – humeral 
head with tendon footprint (Figure 5).    
 
 
 
Figure 5. Lateral view of the tendon-bone repair construct comprising superficial 
layer – cortical DBM/dermal matrix, central layer – fibrin glue with MSCs, and deep 
layer – humeral head with tendon footprint.     
 
A layered wound closure was undertaken in a similar manner to the first surgery, and 
the animals were permitted unrestricted cage activity. Postoperative analgesia (Intra-
muscular Buprenorphine 0.6 mg) was given every 12 hours for three days.  
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Mesenchymal Stem Cell Tracking  
 
QDs are semiconductor nanoparticles that are phagocytosed or taken up by 
pinocytosis into cells and distributed within cytoplasmic vesicles, causing the cells to 
intensely fluoresce. 31 MSCs were able to be tracked using this method. Properties 
that make QDs suitable for cell tracking include their compatibility with MSCs 
without effecting proliferation and differentiation, and their resistance to chemical and 
metabolic degradation. 2, 8, 10, 13, 22, 31  
 
In this study, three animals (one from each experimental group) received MSCs 
labeled with a Q-Tracker 655 Cell Labeling kit (Thermo Fisher Scientific, 
Massachusetts, United States). QDs were applied to cells at a concentration of 
300,000 particle units/1 × 106 MSCs. On the morning of surgery transduced MSCs 
were suspended in the fibrin sealant, stored in plain DMEM, and implanted at the 
repair site as described above.  
 
Histological Assessment 
 
At euthanasia, the right shoulder was dissected and a specimen comprising the 
humerus with its attached supraspinatus musculotendinous unit was removed. Each 
sample was fixed in 10% formal saline and underwent decalcification in EDTA, 
ascending graded alcohol dehydration, defatting in chloroform, and embedding in 
paraffin. Using a Reichert-Jung Model 1130 microtome (Reichert-Jung, Vienna, 
Austria), multiple 4 μm thick slides were cut in the coronal plane through the 
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humerus, enthesis, and supraspinatus musculotendinous unit before staining with 
H&E.  
 
Two blinded observers evaluated all sections using an Olympus BH-2 light 
microscope (Olympus, Glasgow, UK). Tendon degeneration was assessed according 
to a modified Movin scale that was initially conceived to define microstructural 
features of Achilles tendinopathy. 30 It has subsequently been used as a semi-
quantitative scoring system to assess tendon degeneration and includes the following 
variables: (1) fiber structure, (2) fiber arrangement, (3) rounding of the nuclei, (4) 
regional variations in cellularity, (5) increased vascularity, and (6) hyalinisation. 4 A 
four-point scoring system was used: 0 = normal appearance, 1 = slightly abnormal 
appearance, 2 = a moderately abnormal appearance, and 3 = a markedly abnormal 
appearance. 27 Based on this, the total score for any given slide could range from 0 
(normal tendon) to 18 (the greatest level of degeneration). 
 
Maturation of the enthesis was assessed according to the scoring system developed by 
Ide et al that was initially used to characterise the histological features of the tendon-
bone interface of rats in which supraspinatus fixation was achieved using a dermal 
matrix graft. 21 It is a semi-quantitative scoring system ranging from 1-4 (1 being a 
poorly defined enthesis and 4 being a well defined enthesis): score 1 – the insertion 
had continuity without fibrous tissue or bone ingrowth, score 2 – the insertion had 
continuity with fibrous tissue ingrowth but no fibrocartilage cells, score 3 – the 
insertion had continuity with fibrous tissue ingrowth and fibrocartilage cells but no 
tidemark, and score 4 – the insertion had continuity with fibrous tissue ingrowth, 
fibrocartilage cells, and a tidemark. 
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Presence of red fluorescence using microscopy was used to confirm the position and 
distribution of the MSCs containing QDs using a fluorescent microscope (Zeiss, 
Cambridge, UK).  
 
pQCT 
 
Changes in bone mineral density at the humeral head were assessed using pQCT 
scanning. One millimeter slices were obtained through the humeral head and 
supraspinatus musculotendinous unit using an XCT 2000 Bone Scanner (Stratec 
Medizintechnik Gmbh, Germany) with Software version 6.20. Controls were obtained 
from the contralateral (non-operated) shoulder in six animals subjected to the same 
rehabilitation conditions as the study groups.     
  
Statistical Analysis  
 
Nonparametric statistical methods were used for all analyses because of the non-
normality of the data in the groups being compared. Numerical data were inputted 
into SPSS software package, version 23 (SPSS Inc, an IBM Company, Chicago, 
Illinois). Mann Whitney U tests were used to compare data between groups. Results 
were considered significant at the p < 0.05 level. In order to determine whether there 
was any benefit in using MSCs the data from this study was compared to a previously 
published one that evaluated the effect of DBM and dermal matrix on enthesis healing 
in the same chronic rotator cuff tear model without the addition of MSCs. 41  
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RESULTS  
 
All animals survived the duration of the study and none had post-operative infection. 
Limping was noted for the first three to five postoperative days but a normal gait 
pattern returned afterwards.  
 
Mesenchymal Stem Cell Tracking 
  
QDs were observed using fluorescent microscopy in all specimens where they were 
implanted, suggesting that the MSCs remained at the tendon-bone interface (Figure 
6). 
 
 
 
Figure 6. QDs at the tendon-bone interface denoted by red florescent cells; when 
viewed under a fluorescent microscope.  
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Macroscopic Findings  
 
At the time of euthanasia there was continuity between the repaired tendon and the 
bone in all groups. There were no infections and none of the repairs had failed as 
illustrated by the intact sutures. Remodeling of the graft material occurred to a greater 
extent in DBM group, whereby the scaffold could not be discerned from other tissue-
types in the regenerated tendon-bone interface. In contrast, the dermal matrix group 
was clearly visible at necropsy. MSC-only specimens demonstrated complete closure 
of the enthesis.  
 
Quantitative Histology 
 
Supraspinatus muscle-scaffold interface 
 
Both scaffolds had remodeled completely and were characterised by a well 
cellularised interface, similar to controls only repaired with MSCs (Figure 7). 
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Figure 7. Photomicrograph of the supraspinatus muscle-scaffold interface at six 
weeks. Specimens stained with H&E. (a) Control: Tendon-bone repair with MSCs. 
(b) DBM + MSCs. (c) Dermal matrix + MSCs. 
 
Enthesis Maturation Score 
  
No significant differences were observed in the enthesis maturation scores between 
experimental groups (Figure 8). DBM had remodeled to a greater extent than the 
dermal matrix, although not completely in all specimens. The median enthesis 
maturation score was 3 (95% CI 2.47 to 3.70) in the MSC group, 3 (95% CI 3 to 3) in 
the DBM + MSC group, and 2.5 (95% CI 1.88 to 3.46) in the dermal matrix + MSC 
group.   
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Figure 8. Photomicrograph of the enthesis at six weeks. Specimens stained with H&E. 
(a) Control: Tendon-bone repair with MSCs, characterised by a graded enthesis 
comprising tendon (T), fibrocartilage (FC), mineralised fibrocartilage, and bone (B). 
(b) DBM + MSCs: DBM neo enthesis comprising a well-organised, graded enthesis. 
(c) Dermal matrix + MSCs: Dermal matrix neo enthesis with a disorganised structure. 
 
Modified Movin Score  
  
No significant differences in the modified Movin scores (indicating degeneration) 
were demonstrated between experimental groups. The median modified Movin score 
was 4.25 (95% CI 2.19 to 5.48) in the MSC group, 6.75 (95% CI 3.46 to 9.04) in the 
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DBM + MSC group, and 5.75 (95% CI 4.55 to 7.62) in the dermal matrix + MSC 
group.  
 
 Fiber Structure   
 
All groups exhibited increased waviness and distance between collagen fibers. The 
median score was 1 (95% CI 0.12 to 1.55) in the MSC group, 1.75 (95% CI 1.03 to 
2.30) in the DBM + MSC group, and 1.25 (95% CI 0.34 to 1.66) in the dermal matrix 
+ MSC group (Figure 9). No significant inter-group differences were identified.  
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Figure 9. Photomicrograph (under polarised light) showing collagen fiber structure: 
(a) tendon-bone repair using MSCs alone, (b) DBM + MSCs, and (c) Dermal matrix + 
MSCs.    
 
Fiber Arrangement  
  
All groups exhibited a loss of the parallel arrangement observed in an intact tendon-
bone interface). The median score was 1 (95% CI 0.52 to 1.31) in the MSC group, 1 
(95% CI 0.81 to 1.69) in the DBM + MSC group, and 2 (95% CI 1.70 to 2.13) in the 
dermal matrix + MSC group. Fiber arrangement was significantly more abnormal in 
the dermal matrix group than in the DBM group (p = 0.014) and the MSC group (p = 
0.003). No other significant inter-group differences were identified.  
Tenocyte Nuclei   
  
Rounding of nuclei (indicating persistent degeneration) was identified in all groups 
following tendon reattachment. The median score was 1 (95% CI 0.74 to 1.60) in the 
MSC group, 1.50 (95% CI 0.48 to 2.19) in the DBM + MSC group, and 1 (95% CI 
0.79 to 1.88) in the dermal matrix + MSC group. No significant inter-group 
differences were identified.  
 
Cellularity    
  
Specimens were evaluated for an increase in cellularity, indicating persistent 
degeneration. The median score was 1 (95% CI 0.56 to 1.10) in the MSC group, 1.50 
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(95% CI 0.72 to 2.11) in the DBM + MSC group, and 1.25 (95% CI 0.90 to 1.93) in 
the dermal matrix + MSC group. Cellularity was significantly less (indicating less 
noticeable degeneration) in the MSC group than in the dermal matrix group (p = 
0.031). No other significant inter-group differences were identified.  
 
Vascularity  
 
Specimens were evaluated for an increase in vascularity, indicating persistent 
degeneration. 27 The median score was 0 (95% CI -0.13 to 0.30) in the MSC group, 
0.25 (95% CI -0.26 to 1.42) in the DBM + MSC group, and 0.5 (95% CI 0.02 to 0.81) 
in the dermal matrix + MSC group. No significant inter-group differences were 
identified.  
 
Hyalinisation 
 
Hyalinisation was not observed in any of the specimens.  
 
pQCT 
  
Total bone mineral density  
 
Control specimens comprised the contralateral shoulder of animals that had 
undergone unilateral tendon detachment three weeks earlier. In this group (n = 6), the 
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median total bone mineral density at the supraspinatus tendon-bone insertion was 
793.25 mg/ccm (95% CI 754.24 to 844.70). This significantly decreased six weeks 
following repair with dermal matrix + MSCs and repair with MSCs alone to a median 
of 717.25 mg/ccm (95% CI 582.54 to 782.39) (p = 0.010) and 719.65 (95% CI 666.80 
to 765.27) (p = 0.010) respectively. In repairs with DBM + MSCs, median bone 
mineral density was 701.20 mg/ccm (95% CI 621.27 to 794.73). This was not 
significantly different to controls (p = 0.055) (Figure 10). 
 
 
Figure 10. Box and whisker plot showing total bone mineral density at the 
supraspinatus tendon-bone insertion six weeks following repair with MSCs alone, 
cortical DBM and MSCs, and dermal matrix and MSCs.  
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Trabecular bone mineral density  
 
In controls, the median trabecular bone mineral density at the supraspinatus tendon-
bone insertion was 767.05 mg/ccm (95% CI 711.44 to 811.87). This did not 
significantly change following repair with MSCs alone [median of 751.60 mg/ccm 
(95% CI 691.33 to 810.10) (p = 0.52)], with DBM + MSCs [median of 743.65 
mg/ccm (95% CI 653.87 to 877.30) (p = 0.69)], and with dermal matrix + MSCs 
[median of 723.15 mg/ccm (95% CI 598.97 to 823.86) (p = 0.63)]. 
 
Cortical bone mineral density  
 
In controls, the median cortical bone mineral density at the supraspinatus tendon-bone 
insertion was 836.55 mg/ccm (95% CI 753.33 to 907.40). This significantly decreased 
six weeks following repair with MSCs alone [median of 702.50 mg/ccm (95% CI 
632.51 to 742.86) (p = 0.025)], with DBM + MSCs [median of 679.25 mg/ccm (95% 
CI 557.87 to 764.70) (p = 0.016)], and with dermal matrix + MSCs [median of 691.35 
mg/ccm (95% CI 563.44 to 754.26) (p = 0.010)].     
 
Comparison of Histology: MSCs vs No MSCs 
 
Enthesis Maturation Score 
 
Repairs with MSCs alone and DBM + MSCs resulted in a significantly more mature 
enthesis than repairs augmented with dermal matrix alone (p = 0.044 and 0.007 
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respectively). There were no significant differences between other experimental 
groups (Figure 11).  
 
 
Figure 11. Box and whisker plot illustrating the enthesis maturation scores following 
tendon reattachment between MSC and non-MSC groups.   
 
Modified Movin Score 
 
Repairs with MSCs alone resulted in a significantly less degenerative tendon than 
repairs augmented with dermal matrix and non-augmented controls (p = 0.004 and 
0.008 respectively). Furthermore, the addition of MSCs to dermal matrix produced a 
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tendon that was significantly less degenerative (p = 0.025). There were no significant 
differences between other experimental groups (Figure 12). 
 
 
Figure 12. Box and whisker plot illustrating the modified Movin scores following 
tendon reattachment between MSC and non-MSC groups. 
 
pQCT 
 
No significant increase in bone mineral density was conferred by the addition of 
MSCs to the healing interface (Figure 13). 
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Figure 13. Box and whisker plot showing total bone mineral density at the 
supraspinatus tendon-bone insertion six weeks following repair with and without 
MSCs.   
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DISCUSSION  
 
In this study, we hypothesised that compared to MSCs alone, DBM + MSCs would 
regenerate a morphologically superior enthesis characterised by greater fibrocartilage 
formation and improved collagen fiber organisation in a rat model of a chronic rotator 
cuff tear. We further hypothesised that DBM would result in a higher bone mineral 
density at the insertion site. These hypotheses though, are only partially supported by 
the results.  
 
Using a rat model of a chronic rotator cuff tear, tendons were reattached to their bony 
insertion with DBM + MSCs, dermal matrix+ MSCs, and MSCs alone (controls), and 
analysed after six weeks. MSCs were confined to the healing enthesis as illustrated by 
the presence of QDs on fluorescent microscopy. All groups demonstrated closure of 
the tendon-bone gap with a fibrocartilaginous enthesis, but the degenerative process 
could not be reversed (as illustrated by a persistently high Modified Movin score). 
Although there were no significant differences in the enthesis maturation and 
Modified Movin scores, repairs augmented with dermal matrix + MSCs exhibited a 
disorganised enthesis, abnormal collagen fiber arrangement, and greater cellularity 
(indicating persistent degeneration) compared to other MSC groups. In addition to 
these histological parameters, bone mineral density at the enthesis was examined. 
This showed that only repairs augmented with DBM + MSCs reached a total bone 
mineral density not significantly lower than non-operated controls, although the 
absolute values were similar to the other experimental groups. This may be due to the 
upper range of the data set skewing the statistical analysis and we speculate that this 
difference would become more apparent with a larger sample size. Furthermore, this 
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was not noted in a previous study where DBM was applied to a chronic rotator cuff 
tear model without MSCs. 41 We postulate that this may be due to endogenous growth 
factors within DBM (e.g. BMPs) causing MSCs to differentiate into osteoblasts and 
subsequently lead to new bone formation by activating SMAD proteins and increasing 
expression of RUNX2. 23 Low bone mineral density has been identified as an 
independent risk factor for postoperative rotator cuff healing and so it is plausible that 
the small improvement demonstrated in this study may improve tendon healing in 
vivo through its effect on increasing the pullout strength of suture anchors. However 
this does need to be investigated more comprehensively to determine whether this 
difference is maintained at later time points (to withstand the high forces exerted on 
the repair construct during rehabilitation) and to define the precise cellular mechanism 
responsible for it. 9, 45    
 
To determine whether MSCs could enhance the structure of the healing enthesis 
compared to repairs without stem cells, the results of this experiment were compared 
to a previously published study that utilised the same animal model and scaffolds. 41 It 
was hypothesised that the addition of MSCs would yield a morphologically superior 
interface. This was partially supported by the results, in that groups treated with 
MSCs alone and DBM + MSCs resulted in a more mature enthesis (characterised by a 
significantly higher enthesis maturation score) than those repaired with dermal matrix. 
The addition of MSCs to dermal matrix produced a tendon that was significantly less 
degenerative (characterised by a lower Modified Movin score). Furthermore, repairs 
with MSCs alone produced a tendon that was significantly less degenerative than non-
augmented controls and repairs enhanced with dermal matrix. This highlights a 
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supplementary role of MSCs in enthesis healing when used in conjunction with 
biological scaffolds.  
 
Several in vivo studies have evaluated the use of MSCs in tendon-bone healing. 17-20 
In a severe model of acute tendon retraction, Thangarajah et al 42 applied DBM 
incorporated with MSCs (derived from the mononuclear fraction of a bone marrow 
aspirate) to the healing enthesis. At 12 weeks, there was reconstitution of the tendon-
bone interface with a predominance of mineralised fibrocartilage, and an 
improvement in functional weight bearing. In a non-degenerative rotator cuff tear 
model, Gulotta et al 17 applied MSCs to an acutely detached supraspinatus tendon. At 
four weeks, the biomechanical strengths of the repairs were equal between MSC and 
control groups, and there was no difference in the amount of new cartilage formation 
or collagen fiber organisation. This was attributed to a lack of growth/transcription 
factors and so further studies evaluated the effect of membrane type 1 matrix 
metalloproteinase (MT1-MMP) on MSCs and MSCs transduced with adenoviral-
mediated scleraxis (Ad-Scx). 18, 19 The results suggested that MSCs used in this 
context could result in more fibrocartilage, a higher ultimate load to failure, and a 
higher ultimate stress to failure. 
 
The current study could not reproduce the results of MSC-induced tendon-bone 
healing observed in other animal models, even in the presence of DBM. 18, 19, 42 This 
is most likely due to the limited tendon-bone surface area in a rat model not 
presenting an environment that is as conducive to healing as large animal models and 
those that utilise a tendon-bone tunnel. 15, 17 DBM contains multiple growth factors 
such as BMPs and transforming growth factors (TGFs). 35, 36, 47-49 We speculate that 
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these were released slowly over time and were therefore unable to completely exert 
their effect on the MSCs during the six weeks where enthesis healing was permitted 
to take place.  
 
Limitations of this study are principally due to the short time-period (six weeks) over 
which the healing enthesis was allowed to develop. It is feasible that with a longer 
study protocol, the new bony ingrowth in the DBM group that led to a preservation of 
bone mineral density compared to other experimental groups where bone mineral 
density had decreased, could have developed into fibrocartilage and mineralised 
fibrocartilage. A larger number of animals within the groups may have resulted in 
more significant values and a clearer indication of the benefits or drawbacks of the 
treatments. The lack of biomechanical testing precludes discussion about functional 
recovery of the enthesis, which is a particularly important consideration in the clinical 
setting as this may affect the type and success of postoperative rehabilitation 
following rotator cuff repair.       
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CONCLUSION  
 
In conclusion, this study demonstrated that when DBM and MSCs were applied to the 
healing enthesis in a chronic rotator cuff tear model, a fibrocartilaginous-based 
structure was produced, albeit not significantly more mature than other experimental 
groups. Aside from these important histological findings, pQCT analysis showed that 
it was only in the DBM + MSC specimens where bone mineral density was not 
significantly different to non-operated controls.  
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